Roles of the Tau Gene Short Tandem Repeats in Late-Onset Alzheimer's Disease

REFERENCES

• Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprote in E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–3.
   PubMedGoogle Scholar
• Feng YQ, Wang JH, Guo X, Zhao DW, Gao JS, ZF. Analysis of the polymorphisms of apoE gene and ACE gene in Alzheimer's disease and vascular dementia. Chin J Geriatr Heart Brain Vessel Dis. 2004;6:181–3..
   Google Scholar
• Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet. 2006;368:387–403.
   PubMedGoogle Scholar
• Lilius L, Fabre SF, Basun H, Forsell C, Axelman K, Mattila K, Andreadis A, Viitanen M, Winblad B, Fratiglioni L, Lannfelt L. Tau gene polymorphisms and apolipoprotein Eε4 may interact to increase risk for Alzheimer's disease. Neurosci Lett. 1999;277:29–32.
   PubMedGoogle Scholar
• Laws SM, Friedrich P, Diehl-Schmid J, Muller J, Eisele T, Bauml J, Forstl H, Kurz A, Riemenschneider M. Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease. Mol Psychiatry. 2007;12:510–17.
   Google Scholar
• Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L, Lees A, Leung D, McKeith IG, Perry RH, Morris CM, Trojanowski JQ, Clark C, Karlawish J, Arnold S, Forman MS, Van Deerlin V, de Silva R, Hardy J. The MAPT H1c risk haplotype is associated with increased expression of Tau and especially of 4 repeat containing transcripts. Neurobiol Dis. 2007;25:561–70.
   PubMedGoogle Scholar
• Ghetti B, Spina S, Murrell JR, Huey ED, Pietrini P, Sweeney B, Wassermann EM, Keohane C, Farlow MR, Grafman J. In vivo and postmortem clinicoanatomical correlations in frontotemporal dementia and parkinsonism linked to chromosome 17. Neurodegener Dis. 2008;5:215–17.
   Google Scholar
• Bullido MJ, Aldudo J, Frank A, Coria F, Avila J, Valdivieso F. A polymorphism in the Tau gene associated with risk for Alzheimer's disease. Neurosci Lett. 2000;278:49–52.
   PubMedGoogle Scholar
• Mukherjee O, Kauwe JS, Mayo K, Morris JC, Goate AM. Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease. BMC Genet. 2007;8:3.
   PubMed Web of Science ®Google Scholar
• Spina S, Farlow MR, Unverzagt FW, Kareken DA, Murrell JR, Fraser G, Epperson F, Crowther RA, Spillantini MG, Goedert M, Ghetti B. The tauopathy associated with mutation + 3 in intron 10 of Tau: characterization of the MSTD family. Brain. 2008;131:72–89.
   PubMedGoogle Scholar
• Sun WJ, Jia JP. The +347 C promoter allele up-regulates MAPT expression and is associated with Alzheimer's disease among the Chinese Han. Neurosci Lett. 2009;450:340–43.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
   Google Scholar
• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS–ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939–44.
   PubMedGoogle Scholar
• Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Scheinberg P. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS–AIREN international workshop. Neurology. 1993;43:250–60.
   PubMedGoogle Scholar
• Huang K, Tang W, Tang RQ, Xu Z, Li XW, He G, Feng GY, He L, Shi YY. Positive association between OLIG2 and schizophrenia in the Chinese Han population. Hum Genet. 2008;122:659–60.
   PubMedGoogle Scholar
• Iqbal K, Alonso AC, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Tanimukai H, Rahman A, Grundke-Iqbal I. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta. 2005;1739:198–210.
   PubMedGoogle Scholar
• Kalaria, RN, Kenny, RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuro pathological substrates of vascular dementia. J Neurol Sci. 2004;226: 75–80.
   PubMedGoogle Scholar
• Crawford F, Freeman M, Town T, Fallin D, Gold M, Duara R., Mullan M. No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples. Neurosci Lett. 1999;14:193–6.
   Google Scholar
• Roks G, Dermaut B, Heutink P, Julliams A, Backhovens H, de Broeck, MV, Serneels S, Hofman A, Van Broeckhoven C, van Duijn CM, Cruts M. Mutation screening of the Tau gene in patients with early-onset Alzheimer's disease. Neurosci Lett. 1999;277:137–9.
   PubMedGoogle Scholar
• Conrad C, Vianna C, Freeman M, Davies P. A polymorphic gene nested within an intron of the Tau gene: implications for Alzheimer's disease. Proc Natl Acad Sci. 2002;99:7751–6.
   PubMedGoogle Scholar
• Lin KG, Tang M, Guo YB, Han HY, Lin YH, Ma C. The Q7R polymorphism in the Saitohin gene is rare in a southern Chinese population. Neurol Sci. 2008;29:431–4.
   PubMedGoogle Scholar
• Mark D, Daniel G, Eric J, David MA, Stuart PB, Andrew J. Familial early-onset dementia with Tau intron 10+16 mutation with clinical features similar to those of Alzheimer disease. Arch Neurol. 2007;64:1535–9.
   PubMedGoogle Scholar
• Wolfe MS. Tau mutations in neurodegenerative diseases. Biol Chem. 2009;6:6021–5
   Google Scholar
• Levecque C, Elbaz A, Clavel J, Vidal JS, Amouyel P, Alpérovitch A, Tzourio C, Chartier-Harlin MC. Association of polymorphisms in the Tau and Saitohin genes with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004;75:478–80.
   PubMedGoogle Scholar
• Thaker U, McDonagh AM, Iwatsubo T, Lendon CL, Pickering-Brown SM, Mann DM. Tau load is associated with apolipoprotein E genotype and the amount of amyloid βprotein, Aβ40, in sporadic and familial Alzheimer's disease. Neuropath Appl Neuro. 2003;29:35–44.
   PubMedGoogle Scholar
• Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M. Association of an extended haplotype in the Tau gene with progressive supranuclear palsy. Hum Mol Genet. 1999;8:711–15.
   Google Scholar
• Evans W, Fung HC, Steele J, Eerola J, Tienari P, Pittman A, Silva R, Myers A, Vrieze FW, Singleton A, Hardy J. The Tau H2 haplotype is almost exclusively Caucasian in origin. Neurosci Lett. 2004;369:183–5.
   PubMedGoogle Scholar
• Tobin JE, Latourelle JC, Lew MF, Lew C, Klein O, Suchowersky HA, Shill LI, Golbe MH, Mark JH, Growdon GF, Wooten BA, Racette JS, Perlmutter R, Watts M, Guttman KB, Baker S, Goldwurm G, Pezzoli C, Singer MH, Saint-Hilaire AE, Hendricks S, Williamson MW, Nagle JB, Wilk T, Massood JM, Laramie AL, DeStefano I, Litvan G, Nicholson A, Corbett S, Isaacson DJ, Burn PF, Chinnery PP, Pramstaller S, Sherman J, Al-hinti E, Drasby M, Nance AT, Moller K, Ostergaard R, Roxburgh B, Snow JT, Slevin F, Cambi JF, Gusella , MyersRH. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The GenePD Study. Neurology. 2008;71:28–34.
   PubMedGoogle Scholar